PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestment Co. Regulatory News (INV)

Share Price Information for Investment Co. (INV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 325.00
Bid: 320.00
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.125%)
Open: 325.00
High: 325.00
Low: 325.00
Prev. Close: 325.00
INV Live PriceLast checked at -
Investment Company is an Investment Trust

To provide shareholders with an attractive level of dividends coupled with capital growth over the long-term, through the investment in a portfolio of equities, preference shares, loan stocks, debentures and convertibles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2nd Interim Statement

8 May 2013 07:30

RNS Number : 1714E
Investment Company PLC
08 May 2013
 



 

 

 

 

 

 

 

 

 

FOUNDED1868

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REGISTERED No. 4205

ENGLAND AND WALES

 

 

 

 

 

 

THE INVESTMENT COMPANY PLC

 

 

 

 

 

 

 

 

 

 

 

UNAUDITED

SECOND INTERIM REPORT

For the twelve month period ended 31 March 2013

 

 

 

 

Chairman's Statement

 

Your Directors have decided to extend the 2012/2013 trading period from twelve months to fifteen months ending on 30th June, 2013. Consequently, in accordance with the London Stock Exchange Listing Agreement we are today issuing an Unaudited Second Interim Report for the twelve months period ending 31st March, 2013.

 

At the same time we are issuing a document setting out your Board's proposals for the future of the Company. Full details have been announced on the Regulatory News Service of the London Stock Exchange this morning. In consequence of these proposals your Board does not intend to declare any further dividend on the Ordinary Shares in respect of the nine month period to 30th June, 2013.

 

It is anticipated that a full Prospectus document will be issued and sent to all shareholders calling a General Meeting before the end of June.

 

The unaudited net asset value per ordinary share at 31st March, 2013 was 390.08p and at 30th April, 2013 was 400.69p. This compares with 315.96p at 31st March, 2012.

 

 

 

Sir David Thomson Bt.

Chairman

 

8 May 2013

 

Registered office:

3rd Floor, Salisbury House

London Wall

London EC2M 5QS

 

 

 

Consolidated Statement of Comprehensive Income

For twelve months ended 31 March 2013

Notes

12 months to

31 March 2013

(unaudited)

Year to

31 March 2012

(audited)

Revenue

Capital

Total

Revenue

Capital

Total

£

£

£

£

£

£

Total income

922,784

-

922,784

1,363,009

-

1,363,009

Administrative expenses

(425,171)

-

(425,171)

(433,590)

-

(433,590)

Loan note interest

(53,583)

-

(53,583)

(71,991)

-

(71,991)

Other finance costs

(349,636)

-

(349,636)

(349,636)

-

(349,636)

Other interest payable

(2,195)

-

(2,195)

(5,454)

-

(5,454)

Realised gains on investments

-

220,111

220,111

-

26,097

26,097

Movement in impairment provisions

-

26,676

26,676

-

(270,261)

(270,261)

Net return before taxation

92,199

246,787

338,986

502,338

(244,164)

258,174

Taxation

-

-

-

-

-

-

Net return after taxation

92,199

246,787

338,986

502,338

(244,164)

258,174

Other comprehensive income/expense

Movement in unrealised appreciation of investments:

Recognised in equity

-

1,222,379

1,222,379

-

7,801

7,801

Recognised in profit or loss

-

(15,330)

(15,330)

-

(146,627)

(146,627)

Total comprehensive income for the period attributable to equity shareholders

92,199

1,453,836

1,546,035

502,338

(382,990)

119,348

Return per 50p Ordinary Share

From net return after taxation

2.26p

13.22p

15.48p

24.23p

(13.08)p

11.15p

From movement in unrealised appreciation of investments:

 

-

 

64.64p

 

64.64p

 

-

 

(7.43)p

 

(7.43)p

Total: Basic and diluted

5

2.26p

77.86p

80.12p

24.23p

(20.51)p

3.72p

Net asset value per 50p Ordinary Share

390.08p

315.96p

All the Company's operations are continuing.

 

 

 

 

Consolidated Statement of Changes in Equity

For twelve months ended 31 March 2013

 

Issued

Capital

 

Share

Premium

 

Own Shares

Held

Capital Redemption

Reserve

 

Revaluation

Reserve

 

Capital

Reserve

 

Revenue

Account

 

 

Total

£

£

£

£

£

£

£

£

Balance at 1 April 2012

1,808,728

1,019,246

(2,919,861)

685,250

2,313,745

4,806,064

684,449

8,397,621

Buy in of own shares

-

-

-

-

-

-

-

-

Movement in unrealised appreciation of investments

 - recognised in equity

-

-

-

-

1,222,379

-

-

1,222,379

- recognised in profit or loss

-

-

-

-

(15,330)

-

-

(15,330)

Net increase in net assets from operations

-

-

-

-

-

246,787

92,199

338,986

Ordinary dividends paid

-

-

-

-

-

-

(112,043)

(112,043)

Participating element of preference dividends paid

-

-

-

-

-

-

(49,948)

(49,948)

Balance at 31 March 2013

1,808,728

1,019,246

(2,919,861)

685,250

3,520,794

5,052,851

614,657

9,781,665

Balance at 1 April 2011

1,808,728

1,019,246

(2,919,861)

685,250

2,452,571

5,050,228

344,102

8,440,264

Movement in unrealised appreciation of investments

 - recognised in equity

-

-

-

-

7,801

-

-

7,801

- recognised in profit or loss

-

-

-

-

(146,627)

-

-

(146,627)

Net increase in net assets from operations

-

-

-

-

-

(244,164)

502,338

258,174

Ordinary dividends paid

-

-

-

-

-

-

(112,043)

(112,043)

Participating element of preference dividends paid

-

-

-

-

-

-

(49,948)

(49,948)

Balance at 31 March 2012

1,808,728

1,019,246

(2,919,861)

685,250

2,313,745

4,806,064

684,449

8,397,621

Consolidated Balance Sheet

At 31 March 2013

31 March

2013

(Unaudited)

£

31 March

2012

(Audited)

£

Investments

Investments at cost

 

12,408,510

 

13,073,264

Unrealised appreciation/(diminution)

377,109

(856,618)

Portfolio investments at market value

12,785,619

12,216,646

Current assets

Trade and other receivables

191,464

214,896

Investments

129,136

182,857

Cash and bank balances

294,918

284,517

615,518

682,270

Current liabilities

Bank overdraft

-

500,000

Preference dividends payable

174,818

174,818

Trade and other payables

215,851

231,974

5% loan notes maturing 2014

365,700

365,700

756,369

1,272,492

Net current (liabilities)

(140,851)

(590,222)

Non-current liabilities

5% loan notes maturing 2015

(365,700)

(731,400)

Participating preference shares

(2,497,403)

(2,497,403)

Net assets

9,781,665

8,397,621

Capital and reserves

Issued capital

1,808,728

1,808,728

Share premium

1,019,246

1,019,246

Own shares held

(2,919,861)

(2,919,861)

Capital redemption reserve

685,250

685,250

Revaluation reserve

3,520,794

2,313,745

Capital reserve

5,052,851

4,806,064

Revenue reserves

614,657

684,449

Shareholders' funds

9,781,665

8,397,621

Net Asset Value per 50p Ordinary share

390.08p

315.96p

Company Number: 4205

 

Consolidated Cash Flow Statement

For the twelve months ended 31 March 2013

Notes

12 months to

31 March

2013

(unaudited)

Year to

31 March

2012

(audited)

£

£

Cash flows from operating activities

Cash received from investments

297,469

417,926

Interest received

616,680

558,386

Sundry income

468

-

Cash paid to and on behalf of employees

(210,495)

(150,175)

Other cash payments

(222,207)

(251,852)

Net cash inflow from operating activities

481,915

574,285

Cash flows from financing activities

Bank interest paid

(2,195)

(5,454)

Loan note interest paid

(53,583)

(71,991)

Loan notes redeemed

(365,700)

(365,702)

Fixed element of dividends paid on preference shares

(349,636)

 

(349,636)

Participating element of dividends paid on preference shares

(49,948)

 

(49,948)

Dividends paid on ordinary shares

(105,706)

(109,962)

Net cash outflow from financing activities

(926,768)

(952,693)

Cash flows from investing activities

Purchase of investments

(353,256)

(1,278,605)

Sale of investments

1,308,510

1,243,114

Net cash inflow/(outflow) from investing activities

 

955,254

 

(35,491)

Net increase/(decrease) in cash and cash equivalents

 

7

 

510,401

 

(413,899)

 

Notes to the Interim Report

1 Financial information

The Investment Company plc is a limited company incorporated in Great Britain and registered in England and Wales, company number 4205. The address of its registered office and principal place of business is 3rd Floor, Salisbury House, London Wall, London EC2M 5QS.

The financial information contained in this second interim financial report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The financial information for the twelve months ended 31 March 2013 has been neither audited nor reviewed by the auditors.

The figures and financial information for the year ended 31 March 2012 are extracted from the latest published audited financial statements of the Company and do not constitute the statutory accounts for that year. The audited financial statements for the year ended 31 March 2012 have been filed with the Registrar of Companies. The report of the independent auditors on those accounts contained no qualification or statement under section 498(2) or section 498(3) of the Companies Act 2006.

Except as described below, the Group has applied consistent accounting policies in preparing the interim financial statements for the twelve months ended 31 March 2013 and the financial statements for the period ended 31 March 2012.

The Group applies revised IAS 1 Presentation of Financial Statements, as a result of which the Company presents in the statement of changes in equity all owner changes in equity, whereas all non-owner changes in equity are presented in the statement of comprehensive income. This standard is concerned with presentation only and does not have any impact on the results or net assets of the Company.

2 Accounting policies

These financial statements have been prepared in accordance with International Accounting Standards (IAS) issued by the International Accounting Standards Board (IASB) as adopted by the EU and in accordance with the Interpretations of International Accounting Standards issued by the Standing Interpretations Committee of the IASB.

These financial statements have been prepared under the historical cost convention, except for Portfolio Investments which are stated at market value.

3 Directors' Responsibility Statement

The Directors confirm that, to the best of their knowledge:

(a) these condensed financial statements have been prepared in accordance with IAS 34;

(b) the interim management report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.7R (an indication of important events that have occurred during the first six months of the financial year and a description of the principal risks and uncertainties for the remaining six months of the financial year); and

(c) the interim management report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).

 

 

 

 

 

 

4 Dividends payable

12 months to

31 March

2013

(unaudited)

Year to

31 March

2012

(audited)

£

£

Participating preference shares

Participating preference element

49,948

49,948

Ordinary shares

Prior year final

74,696

74,696

Current year interim

37,347

37,347

Total dividends

161,991

161,991

5 Return per ordinary share

12 months to

31 March

2013

(unaudited)

Year to

31 March

2012

(audited)

Ordinary shares

1,867,391

1,867,391

£

Per

Share

Pence

£

Per

Share

Pence

Revenue

Net return after taxation

92,199

4.93

502,338

26.90

Participating dividend

(49,948)

(2.67)

(49,948)

(2.67)

Capital

Net investment gains/(losses) after taxation

246,787

13.22

(244,164)

(13.08)

Net return after taxation

289,038

15.48

208,226

11.15

Movement in unrealised appreciation of investments

 

1,207,049

 

64.64

 

(138,826)

 

(7.43)

Total

1,496,087

80.12

69,400

3.72

 

 

As the Company has no options or warrants in issue, basic and diluted earnings per share are the same.

 

6 Preference shares

The participating preference shares entitle the holders, in priority to the payment of any dividend to the holders of all or any other shares in the capital of the company, to a fixed net cash cumulative dividend at the rate of 7p per share per annum. In addition, holders are entitled to a participating dividend at the rate of 25% of any dividends paid on the Ordinary Shares in excess of 2p per share for any year, subject to a maximum participating dividend in respect of any year of 3p net per share. On any return of capital holders are entitled to the payment of a premium of 50p per share.

 

7 Analysis of net debt

At

31 March

2013

(unaudited)

Cash flow

(unaudited)

At

1 April

2012

(audited)

£

£

£

Cash and bank balances

294,918

10,401

284,517

Bank overdraft

-

500,000

(500,000)

5% loan notes maturing March 2014/2015

(731,400)

365,700

(1,097,100)

(436,482)

876,101

(1,312,583)

Participating preference shares

(2,497,403)

-

(2,497,403)

(2,933,885)

876,101

(3,809,986)

8 Movement in Net Asset Value

 £

 p

 p

NAV at 1 April 2012

315.96

Revenue in period

42,251

2.26

Realised gains on investments

220,111

11.79

Movement in impairment provisions

26,676

1.43

246,787

13.22

15.48

Revaluation reserve at period end

3,520,794

Revaluation reserve at start of year

2,313,745

Increase in the year in unrealised appreciation of investments above cost

1,207,049

64.64

Dividends paid to ordinary shareholders

 (112,043)

(6.00)

NAV at 31 March 2013

390.08

IFRS requires diminution in value from the cost of an investment to be reflected through the Consolidated Income Statement. This does not reflect similarly any rise in value above the cost. However once provision for any diminution in value or unrealised loss (known as an Impairment Provision) has been put through the Income Statement, any subsequent recovery up to original cost does go through the Income Statement; but if the value of those investments continues to rise above cost, until that gain is realised it is confined to the Statement of Changes in Equity where it is shown in the Revaluation Reserve on the Balance Sheet.

9 Principal Risks and Uncertainties

The group's financial instruments comprise investments in fixed interest securities and prior charge investments, borrowings for investment purposes, cash balances and debtors and creditors that arise directly from its operations. Its principal risks are market price risk, interest rate risk and liquidity risk. These risks, and the way in which they are managed, are described in more detail within the Company's Annual Report and Accounts for the year ended 31 March 2012. The nature of the Company's principal risks and uncertainties has not changed materially since the date of that report.

10 Related Party Transactions

During the first twelve months of the current financial period, no new transactions with related parties have taken

Place. Details of related party transactions are contained in the Company's Annual Report for the year ended 31 March 2012.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UGUAUAUPWGQM
Date   Source Headline
14th May 20249:56 amRNSNet Asset Value(s)
7th May 20242:17 pmRNSNet Asset Value(s)
29th Apr 20244:56 pmRNSNet Asset Value(s)
22nd Apr 20245:26 pmRNSNet Asset Value(s)
15th Apr 20244:57 pmRNSNet Asset Value(s)
9th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20241:29 pmRNSNet Asset Value(s)
25th Mar 20243:37 pmRNSNet Asset Value(s)
19th Mar 20243:33 pmRNSNet Asset Value(s)
12th Mar 20249:58 amRNSNet Asset Value(s)
5th Mar 20242:56 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSHalf-year Report
27th Feb 202412:54 pmRNSNet Asset Value(s)
19th Feb 20244:00 pmRNSNet Asset Value(s)
15th Feb 20244:24 pmRNSDirector Declaration
6th Feb 20241:34 pmRNSNet Asset Value(s)
29th Jan 202410:24 amRNSNet Asset Value(s)
22nd Jan 20245:38 pmRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
9th Jan 20241:55 pmRNSNet Asset Value(s)
4th Jan 202411:45 amRNSNet Asset Value(s)
27th Dec 20232:08 pmRNSNet Asset Value(s)
18th Dec 20232:11 pmRNSNet Asset Value(s)
12th Dec 20239:32 amRNSNet Asset Value(s)
4th Dec 20231:20 pmRNSNet Asset Value(s)
27th Nov 20233:48 pmRNSNet Asset Value(s)
20th Nov 20233:24 pmRNSNet Asset Value(s)
13th Nov 202310:07 amRNSNet Asset Value(s)
10th Nov 202311:04 amRNSDirector/PDMR Shareholding
9th Nov 202312:07 pmRNSDirector/PDMR Shareholding
7th Nov 202312:03 pmRNSResult of AGM
2nd Nov 20235:04 pmRNSNet Asset Value(s)
31st Oct 20235:06 pmRNSNet Asset Value(s)
23rd Oct 20233:29 pmRNSNet Asset Value(s)
16th Oct 20235:11 pmRNSNet Asset Value(s)
9th Oct 20233:34 pmRNSNet Asset Value(s) - Amendment
9th Oct 20233:19 pmRNSNet Asset Value(s)
6th Oct 202312:02 pmRNSNet Asset Value(s)
4th Oct 20233:22 pmRNSFinal Results
25th Sep 20234:52 pmRNSNet Asset Value(s)
20th Sep 202310:47 amRNSNet Asset Value(s)
11th Sep 20234:40 pmRNSNet Asset Value(s)
9th Aug 20232:04 pmRNSNet Asset Value(s)
9th Aug 202311:24 amRNSHolding(s) in Company
8th Aug 20234:13 pmRNSHolding(s) in Company
1st Aug 202311:09 amRNSTotal Voting Rights
27th Jul 20234:11 pmRNSHolding(s) in Company
27th Jul 20232:36 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSAdmission, Director Dealings & Total Voting Rights
19th Jul 20237:00 amRNSCalculation of the Tender Price and Issue Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.